SCHEMBL5470575

SCHEMBL5470575

Cc1nn(C(=O)OC(C)(C)C)c2ccc(-c3cc(OC[C@H](CO[Si](C)(C)C(C)(C)C)NC(=O)OC(C)(C)C)cnc3-c3ccccc3)cc12

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AKT1 P31749 8/20 0.36
ROCK1 Q13464 6/20 0.34
HDAC3 O15379 1/20 0.32
HDAC4 P56524 1/20 0.32
HDAC1 Q13547 1/20 0.32
HDAC7 Q8WUI4 1/20 0.32
HDAC2 Q92769 1/20 0.32
HDAC10 Q969S8 1/20 0.32
HDAC11 Q96DB2 1/20 0.32
HDAC8 Q9BY41 1/20 0.32
HDAC6 Q9UBN7 1/20 0.32
HDAC9 Q9UKV0 1/20 0.32
HDAC5 Q9UQL6 1/20 0.32
MAP2K4 P45985 1/20 0.32
CSNK1A1 P48729 1/20 0.32
CSNK1D P48730 1/20 0.32
CSNK1E P49674 1/20 0.32
MAPK14 Q16539 1/20 0.32
JAK2 O60674 1/20 0.31
CKS1B P61024 4/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4659872 0.91 AKT1 (0.38) AKT1ROCK1HDAC3HDAC4HDAC1
SCHEMBL5471035 0.91 AKT1 (0.38) AKT1ROCK1HDAC3HDAC4HDAC1
SCHEMBL14430124 0.89 AKT1 (0.43) AKT1ROCK1HDAC3HDAC4HDAC1
SCHEMBL4659874 0.86 AKT1 (0.36) AKT1ROCK1HDAC3HDAC4HDAC1
SCHEMBL14430130 0.84 AKT1 (0.42) AKT1ROCK1HDAC3HDAC4HDAC1
SCHEMBL14430179 0.84 AKT1 (0.42) AKT1ROCK1CSNK1A1CSNK1DCSNK1E
SCHEMBL14430147 0.82 AKT1 (0.43) AKT1ROCK1HDAC3HDAC4HDAC1
SCHEMBL14430150 0.82 AKT1 (0.41) AKT1ROCK1HDAC3HDAC4HDAC1
SCHEMBL14430132 0.82 AKT1 (0.39) AKT1ROCK1HDAC3HDAC4HDAC1
SCHEMBL14430131 0.81 AKT1 (0.38) AKT1ROCK1MAP2K4CSNK1A1CSNK1D

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070185152-A1 Inhibitors of akt activity SMITHKLINE BEECHAM CORPORATION 2007-08-09 US disclosed
US-20070185152-A1 Inhibitors of akt activity SMITHKLINE BEECHAM CORPORATION 2007-08-09 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070185152-A1 Inhibitors of akt activity AKT1, AKT1S1, AKT2 AKT1 1/4885ROCK1 589/4885HDAC3 995/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.